NanoVibronix Reconciled Depreciation vs Research Development Analysis

NAOV Stock

USD 0.72 0.01 1.37%

NanoVibronix financial indicator trend analysis is infinitely more than just investigating NanoVibronix recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether NanoVibronix is a good investment. Please check the relationship between NanoVibronix Reconciled Depreciation and its Research Development accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NanoVibronix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy NanoVibronix Stock please use our How to Invest in NanoVibronix guide.

Reconciled Depreciation vs Research Development

Reconciled Depreciation vs Research Development Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of NanoVibronix Reconciled Depreciation account and Research Development. At this time, the significance of the direction appears to have very strong relationship.

The correlation between NanoVibronix's Reconciled Depreciation and Research Development is 0.84. Overlapping area represents the amount of variation of Reconciled Depreciation that can explain the historical movement of Research Development in the same time period over historical financial statements of NanoVibronix, assuming nothing else is changed. The correlation between historical values of NanoVibronix's Reconciled Depreciation and Research Development is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Reconciled Depreciation of NanoVibronix are associated (or correlated) with its Research Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Research Development has no effect on the direction of Reconciled Depreciation i.e., NanoVibronix's Reconciled Depreciation and Research Development go up and down completely randomly.

Correlation Coefficient

0.84

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Reconciled Depreciation

Research Development

Most indicators from NanoVibronix's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into NanoVibronix current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NanoVibronix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy NanoVibronix Stock please use our How to Invest in NanoVibronix guide.At this time, NanoVibronix's Enterprise Value Over EBITDA is fairly stable compared to the past year. Enterprise Value Multiple is likely to climb to 0.39 in 2024, whereas Selling General Administrative is likely to drop slightly above 2.4 M in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	770K	167K	1.5M	1.6M
Total Revenue	1.7M	752K	2.3M	2.4M

Gross Profit Total Revenue

NanoVibronix fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Common Stock	Inventory	Other Liab	Current Deferred Revenue
Total Assets		-0.53	0.83	0.24	0.83	0.42	-0.9	-0.79	0.43	0.95	-0.11	-0.23	0.95	0.52	-0.41	0.66	-0.17	0.61	0.86	0.14	0.22	1.0	-0.2	0.4	0.09	0.01
Short Long Term Debt Total	-0.53		-0.4	0.55	-0.78	-0.01	0.78	0.58	-0.45	-0.5	0.57	0.57	-0.5	-0.4	-0.07	-0.45	0.03	-0.34	-0.62	0.54	0.05	-0.55	0.73	-0.33	-0.16	-0.47
Other Current Liab	0.83	-0.4		0.44	0.66	0.36	-0.68	-0.88	0.38	0.69	-0.03	-0.14	0.69	0.71	-0.59	0.85	-0.18	0.59	0.79	0.34	0.17	0.82	-0.08	0.73	0.12	-0.15
Total Current Liabilities	0.24	0.55	0.44		-0.19	0.18	0.12	-0.22	0.13	0.15	0.76	0.68	0.15	0.15	-0.32	0.22	-0.23	0.22	0.17	0.84	0.08	0.21	0.7	0.2	0.07	-0.29
Total Stockholder Equity	0.83	-0.78	0.66	-0.19		0.26	-0.9	-0.81	0.41	0.79	-0.4	-0.47	0.79	0.67	-0.22	0.74	-0.38	0.38	0.82	-0.39	0.2	0.84	-0.52	0.52	-0.21	0.02
Property Plant And Equipment Net	0.42	-0.01	0.36	0.18	0.26		-0.24	-0.3	-0.36	0.33	-0.09	-0.28	0.33	-0.05	-0.59	0.32	-0.02	0.64	0.39	0.16	0.92	0.43	-0.07	0.19	-0.11	-0.49
Net Debt	-0.9	0.78	-0.68	0.12	-0.9	-0.24		0.7	-0.48	-0.93	0.31	0.39	-0.93	-0.47	0.21	-0.55	0.05	-0.51	-0.76	0.14	-0.05	-0.91	0.45	-0.27	-0.19	-0.28
Retained Earnings	-0.79	0.58	-0.88	-0.22	-0.81	-0.3	0.7		-0.48	-0.61	0.13	0.21	-0.61	-0.83	0.34	-0.94	0.49	-0.49	-0.94	0.05	-0.24	-0.78	0.21	-0.79	0.16	0.09
Accounts Payable	0.43	-0.45	0.38	0.13	0.41	-0.36	-0.48	-0.48		0.4	0.25	0.29	0.4	0.35	0.45	0.25	-0.28	0.19	0.5	-0.04	-0.46	0.41	0.07	0.16	0.1	0.61
Cash	0.95	-0.5	0.69	0.15	0.79	0.33	-0.93	-0.61	0.4		-0.1	-0.21	1.0	0.39	-0.32	0.47	-0.03	0.52	0.69	0.12	0.11	0.95	-0.21	0.15	0.19	0.12
Non Current Assets Total	-0.11	0.57	-0.03	0.76	-0.4	-0.09	0.31	0.13	0.25	-0.1		0.98	-0.1	-0.21	0.2	-0.19	-0.27	-0.06	-0.15	0.57	-0.07	-0.15	0.67	-0.21	0.03	0.05
Non Currrent Assets Other	-0.23	0.57	-0.14	0.68	-0.47	-0.28	0.39	0.21	0.29	-0.21	0.98		-0.21	-0.21	0.33	-0.27	-0.27	-0.21	-0.24	0.5	-0.24	-0.26	0.66	-0.24	0.03	0.14
Cash And Short Term Investments	0.95	-0.5	0.69	0.15	0.79	0.33	-0.93	-0.61	0.4	1.0	-0.1	-0.21		0.39	-0.32	0.47	-0.03	0.52	0.69	0.12	0.11	0.95	-0.21	0.15	0.19	0.12
Net Receivables	0.52	-0.4	0.71	0.15	0.67	-0.05	-0.47	-0.83	0.35	0.39	-0.21	-0.21	0.39		-0.36	0.9	-0.53	0.01	0.66	-0.13	-0.02	0.52	-0.16	0.81	-0.33	-0.28
Common Stock Total Equity	-0.41	-0.07	-0.59	-0.32	-0.22	-0.59	0.21	0.34	0.45	-0.32	0.2	0.33	-0.32	-0.36		-0.53	-0.18	-0.25	-0.26	-0.42	-0.47	-0.42	0.07	-0.48	-0.09	0.68
Common Stock Shares Outstanding	0.66	-0.45	0.85	0.22	0.74	0.32	-0.55	-0.94	0.25	0.47	-0.19	-0.27	0.47	0.9	-0.53		-0.5	0.3	0.81	-0.05	0.32	0.66	-0.19	0.91	-0.28	-0.36
Non Current Liabilities Total	-0.17	0.03	-0.18	-0.23	-0.38	-0.02	0.05	0.49	-0.28	-0.03	-0.27	-0.27	-0.03	-0.53	-0.18	-0.5		0.11	-0.43	0.34	-0.24	-0.16	-0.04	-0.47	0.8	0.29
Other Current Assets	0.61	-0.34	0.59	0.22	0.38	0.64	-0.51	-0.49	0.19	0.52	-0.06	-0.21	0.52	0.01	-0.25	0.3	0.11		0.58	0.28	0.38	0.61	-0.14	0.2	0.3	0.14
Other Stockholder Equity	0.86	-0.62	0.79	0.17	0.82	0.39	-0.76	-0.94	0.5	0.69	-0.15	-0.24	0.69	0.66	-0.26	0.81	-0.43	0.58		-0.08	0.31	0.86	-0.25	0.61	-0.12	0.0
Total Liab	0.14	0.54	0.34	0.84	-0.39	0.16	0.14	0.05	-0.04	0.12	0.57	0.5	0.12	-0.13	-0.42	-0.05	0.34	0.28	-0.08		-0.06	0.11	0.64	-0.05	0.52	-0.12
Property Plant And Equipment Gross	0.22	0.05	0.17	0.08	0.2	0.92	-0.05	-0.24	-0.46	0.11	-0.07	-0.24	0.11	-0.02	-0.47	0.32	-0.24	0.38	0.31	-0.06		0.23	-0.05	0.23	-0.37	-0.61
Total Current Assets	1.0	-0.55	0.82	0.21	0.84	0.43	-0.91	-0.78	0.41	0.95	-0.15	-0.26	0.95	0.52	-0.42	0.66	-0.16	0.61	0.86	0.11	0.23		-0.23	0.4	0.09	0.01
Common Stock	-0.2	0.73	-0.08	0.7	-0.52	-0.07	0.45	0.21	0.07	-0.21	0.67	0.66	-0.21	-0.16	0.07	-0.19	-0.04	-0.14	-0.25	0.64	-0.05	-0.23		-0.16	0.04	-0.15
Inventory	0.4	-0.33	0.73	0.2	0.52	0.19	-0.27	-0.79	0.16	0.15	-0.21	-0.24	0.15	0.81	-0.48	0.91	-0.47	0.2	0.61	-0.05	0.23	0.4	-0.16		-0.31	-0.38
Other Liab	0.09	-0.16	0.12	0.07	-0.21	-0.11	-0.19	0.16	0.1	0.19	0.03	0.03	0.19	-0.33	-0.09	-0.28	0.8	0.3	-0.12	0.52	-0.37	0.09	0.04	-0.31		0.58
Current Deferred Revenue	0.01	-0.47	-0.15	-0.29	0.02	-0.49	-0.28	0.09	0.61	0.12	0.05	0.14	0.12	-0.28	0.68	-0.36	0.29	0.14	0.0	-0.12	-0.61	0.01	-0.15	-0.38	0.58

Click cells to compare fundamentals

NanoVibronix Account Relationship Matchups

NanoVibronix fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	2.0M	8.2M	8.6M	5.9M	6.7M	3.7M
Other Current Liab	280K	2.5M	1.7M	2.1M	2.3M	2.4M
Total Current Liabilities	409K	2.9M	1.9M	2.3M	2.5M	1.8M
Total Stockholder Equity	1.3M	2.4M	6.3M	3.2M	4.0M	4.2M
Property Plant And Equipment Net	4K	35K	54K	88K	12K	11.4K
Net Debt	(1.3M)	(7.1M)	(7.7M)	(2.6M)	(3.3M)	(3.1M)
Retained Earnings	(38.3M)	(42.7M)	(56.9M)	(62.4M)	(66.1M)	(62.8M)
Accounts Payable	129K	144K	87K	66K	138K	103.5K
Cash	1.3M	7.1M	7.7M	2.7M	3.3M	2.6M
Non Current Assets Total	198K	259K	280K	270K	187K	228.2K
Non Currrent Assets Other	194K	200K	207K	179K	175K	205.1K
Cash And Short Term Investments	1.3M	7.1M	7.7M	2.7M	3.3M	2.6M
Net Receivables	130K	93K	264K	109K	425K	446.3K
Common Stock Shares Outstanding	347.0K	514.9K	1.3M	1.4M	1.8M	1.8M
Liabilities And Stockholders Equity	2.0M	8.2M	8.6M	5.9M	6.7M	3.7M
Non Current Liabilities Total	279K	2.9M	406K	330K	232K	220.4K
Other Current Assets	249K	590K	166K	612K	47K	44.7K
Other Stockholder Equity	39.7M	45.0M	63.2M	65.6M	70.1M	36.5M
Total Liab	688K	5.8M	2.3M	2.6M	2.7M	2.2M
Property Plant And Equipment Gross	4K	4.0	54K	88K	12K	11.4K
Total Current Assets	1.8M	8.0M	8.3M	5.6M	6.5M	3.3M
Accumulated Other Comprehensive Income	(54K)	66K	60K	(18K)	(67K)	(70.4K)
Inventory	121K	145K	175K	2.2M	2.7M	2.9M
Other Liab	279K	2.9M	406K	330K	297K	282.2K
Other Assets	194K	255.0	208K	179K	161.1K	216.3K
Net Tangible Assets	1.3M	2.4M	6.3M	3.2M	3.7M	3.9M
Capital Surpluse	32.0M	33.0M	39.7M	45.0M	51.7M	31.5M
Retained Earnings Total Equity	(28.4M)	(32.6M)	(38.3M)	(42.7M)	(38.4M)	(40.3M)
Non Current Liabilities Other	434K	477K	279K	462K	415.8K	796.7K
Net Invested Capital	1.3M	2.4M	6.3M	3.2M	4.0M	3.4M
Net Working Capital	1.4M	5.1M	6.4M	3.3M	4.0M	3.9M
Capital Stock	9K	24K	28K	2K	1.8K	1.7K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for NanoVibronix Stock Analysis

When running NanoVibronix's price analysis, check to measure NanoVibronix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NanoVibronix is operating at the current time. Most of NanoVibronix's value examination focuses on studying past and present price action to predict the probability of NanoVibronix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NanoVibronix's price. Additionally, you may evaluate how the addition of NanoVibronix to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC